Author:
Sandhu Naemat,Rossi Simona
Publisher
Springer International Publishing
Reference84 articles.
1. Globocan. Liver Cancer Global WHO Report. Iarc. 2018;876:2018–9. Available from: http://gco.iarc.fr/today
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
3. Seer. SEER Cancer Statistics Review 1975–2006. National Cancer Institute SEER cancer statistics review 1975–2006 National Cancer Institute. Cancer. 2008:1975–2006.
4. El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology. 2014;60(5):1767–75.
5. Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul JL, et al. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. Available from: https://doi.org/10.1016/j.jhep.2018.03.019.